To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·12-14 07:13
      ARKG Investment Tracker position change: Decreased position in Prime Medicine, Inc. by 47,648 shares, the number of shares held decreased 0.94% compared to the previous period and now represents 1.67% of the total position.
      757Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·12-14 07:13
      ARKG Investment Tracker position change: Decreased position in Veeva by 384 shares, the number of shares held decreased 0.92% compared to the previous period and now represents 0.74% of the total position.
      164Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·12-14 07:13
      ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 248 shares, the number of shares held decreased 0.94% compared to the previous period and now represents 0.91% of the total position.
      473Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·12-14 07:13
      ARKG Investment Tracker position change: Decreased position in Incyte by 1,296 shares, the number of shares held decreased 0.94% compared to the previous period and now represents 1.03% of the total position.
      81Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·12-14 07:13
      ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 1,768 shares, the number of shares held decreased 0.94% compared to the previous period and now represents 2.26% of the total position.
      96Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·12-14 07:13
      ARKG Investment Tracker position change: Increased position in Nurix Therapeutics by 11,968 shares, the number of shares held increased 0.75% compared to the previous period and now represents 2.39% of the total position.
      186Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·12-14 07:13
      ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 34,200 shares, the number of shares held decreased 1.06% compared to the previous period and now represents 2.38% of the total position.
      278Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·12-14 07:13
      ARKG Investment Tracker position change: Decreased position in Amgen by 424 shares, the number of shares held decreased 0.93% compared to the previous period and now represents 1.12% of the total position.
      125Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·12-14 07:13
      ARKG Investment Tracker position change: Decreased position in Atai Beckley Inc by 31,536 shares, the number of shares held decreased 0.94% compared to the previous period and now represents 1.15% of the total position.
      68Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·12-14 07:13
      ARKG Investment Tracker position change: Decreased position in Illumina by 3,968 shares, the number of shares held decreased 0.94% compared to the previous period and now represents 4.46% of the total position.
      84Comment
      Report
       
       
       
       

      Most Discussed